PHIL gives insight into the tens of millions of dollars in

New Post Public Reply Private Reply Replies (1) Message Board
prof IDFIX #108
PHIL gives insight into the tens of millions of dollars in revenue about to begin with latest PR

NEW YORK, Dec. 16, 2016 (GLOBE NEWSWIRE) -- PHI Group, a U.S. diversified holding company focusing on acquisitions and investments in special situations (www.phiglobal.com); (PHIL), has signed an agreement with Mr. Van M. Pham, an expert in immunology, microbiology, agricultural nutrients and breeding, to secure intellectual properties for application of proprietary natural immune and symbiotic microbe systems in premium organic husbandry.

According to the signed Intellectual Property Contribution and Assignment Agreement, Mr. Pham has contributed and assigned to PHI Group the entire rights, title and interest in all the Intellectual Properties that Mr. Pham has developed and continues to develop, with respect to proprietary formulations of natural immune and symbiotic microbe systems that can be customized for agriculture such as raising premium organic poultry, cattle, and other livestock and cultivating plants, medicinal herbs, and other products without using antibiotics, synthetic fertilizers or chemical pesticides.

Mr. Pham received his training in Europe under the auspices of the United Nations’ Food and Agriculture Organization (FAO) and served as an agricultural specialist under the Ministry of Agricultural and Rural Development of Vietnam for 17 years. He has successfully applied proprietary natural immune and symbiotic microbe systems for poultry, livestock, aquacultural products and various agricultural crops without the use of antibiotics, vaccines, synthetic fertilizers, chemical pesticides or disinfectants, thus being able to produce premium organic, healthy food products that can greatly improve human health.

Together with Henry Fahman, CEO of PHI Group, Mr. Pham recently visited the farm in Holmes County, Florida that the Company is in the process of acquiring in order to assess the soil and water for the next planting season. We plan to focus first on growing several specialty medicinal plants and fruits, aiming to meet orders of approximately $45 million from prospective customers in Asia. In addition, we also raise premium organic poultry and other livestock to generate imminent cash flows and develop a model farming program without antibiotics and chemicals that can be replicated and licensed to farmers worldwide.

Mr. Pham said: “I am delighted to work with PHI Group to advance our premium organic husbandry program and provide the best organic crops and livestock that humans can consume, thereby dramatically improving human health and longevity.”

“We look forward to sharing our premium organic farming results in Florida and the benefits of our technologies with other farmers in the very near future,” Mr. Pham added.

http://finance.yahoo.com/news/phi-group-acqui...00116.html

prof

Phi Group Inc (PHIL) Stock Research Links

PHIL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Nvidia's Major $500 Million Investment in Wayve for AI Expansion

Updated Category News Views 206

Nvidia Invests $500 Million in Wayve Nvidia, known for its advanced AI technologies, is in discussions to invest a substantial $500 million into the U.K.-based autonomous driving startup Wayve. This move marks a significant step for Nvidia as it seeks to deepen its involvement in the rapidly evolving artificial intelligence sector. Strategic Importance of the Investment...

Continue Reading
Vortex Companies Enhances Leadership with Key Promotions

Updated Category News Views 164

Elevating Leadership at Vortex Companies Vortex Companies, known for its rapid growth in the trenchless infrastructure rehabilitation sector, has recently made significant leadership changes with the promotions of Jonathan Thomas and Connor Mathis. Thomas steps into the role of Senior Regional Vice President for the Coastal Region, while Mathis ascends to Regional Vice...

Continue Reading
Scilex Holding Company Receives FDA Acknowledgment for ELYXYB

Updated Category News Views 118

Scilex Holding Company’s FDA Milestone with ELYXYB Scilex Holding Company, based in Palo Alto, California, has gained significant recognition with the U.S. FDA's acknowledgment of their Supplemental New Drug Application (SNDA) for ELYXYB. This marks a substantial step forward for the company, which is dedicated to creating and advancing non-opioid pain management...

Continue Reading
Bio-Techne Expands AI-Driven Protein Portfolio

Updated Category News Views 8

Advanced Proteins in the Spotlight Bio-Techne’s latest move is creating some serious buzz in the life sciences scene. They're not just talking the talk but walking the walk by expanding their R&D Systems AI-Engineered Designer Protein portfolio. What's the big news? They've engineered heat-stable and hyperactive proteins that promise to shake up fibroblast growth factor...

Continue Reading
PolyPid's D-PLEX100 Trial Results Revolutionize Infection Prevention

Updated Category News Views 146

Groundbreaking Advances in Surgical Infection Prevention PolyPid Ltd. has made headlines recently, unveiling remarkable topline results from their pivotal SHIELD II Phase 3 trial. This innovative study showcased D-PLEX100, a major breakthrough in preventing surgical site infections (SSIs), showing statistically significant reductions in both primary and secondary...

Continue Reading